Wall Street firm Jefferies believes certain biotechnology stocks are poised to benefit from AI advancements. Analyst Michael Yee told CNBC that the sector is likely to save billions of dollars as well ...
Akari Therapeutics is an oncology biotechnology company developing next-generation spliceosome payload antibody drug conjugates (ADCs). Utilizing its innovative ADC discovery platform, the Company has ...
Tech titans are investing in startups in hopes of cheating death. Other rich investors, driven by their own ailments and family deaths, are betting on biotech. Four longevity investors told BI how ...
Exchange-traded funds that track companies in the biotechnology industry were surging on Tuesday afternoon as large-cap stocks lost ground and investors turned to small-cap names. The SPDR S&P Biotech ...
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's ...
The event will focus on UNITY’s ongoing Phase 2b ASPIRE study evaluating foselutoclax (UBX1325) head-to-head against aflibercept in diabetic macular edema (DME). Twenty-four-week safety and efficacy ...
Wall Street firm Jefferies believes certain biotechnology stocks are poised to benefit from AI advancements. Analyst Michael Yee told CNBC that the sector is likely to save billions of dollars as well ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback